Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2024 | Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study | JOURNAL OF CLINICAL ONCOLOGY |